SNGX

SNGX

USD

Soligenix Inc. Common Stock

$1.340-0.100 (-6.944%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$1.440

Haut

$1.470

Bas

$1.300

Volume

0.24M

Fondamentaux de l'Entreprise

Capitalisation Boursière

11.2M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

4.32M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.09Actuel $1.340Haut $6.23

Actualités Connexes

PR Newswire

Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...

Voir plus
Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma
PR Newswire

Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...

Voir plus
Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
PR Newswire

Soligenix Announces Closing of $7.5 Million Public Offering

Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...

Voir plus
Soligenix Announces Closing of $7.5 Million Public Offering
PR Newswire

Soligenix Announces Pricing of $7.5 Million Public Offering

Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...

Voir plus
Soligenix Announces Pricing of $7.5 Million Public Offering

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.